Repurposing pentosan polysulfate sodium as hyaluronic acid linked polyion complex nanoparticles for the management of osteoarthritis: A potential approach.
Sign Up to like & getrecommendations! Published in 2021 at "Medical hypotheses"
DOI: 10.1016/j.mehy.2021.110713
Abstract: Osteoarthritis is still a disease burden for pharmaceutical scientists and strategy makers. It is associated with the chronic inflammation of joints especially weight-bearing joints like knee, hip, backbone, and phalanges. NSAIDs that are used for… read more here.
Keywords: polyion complex; management; hyaluronic acid; acid linked ... See more keywords
Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy
Sign Up to like & getrecommendations! Published in 2021 at "Optometry and Vision Science"
DOI: 10.1097/opx.0000000000001702
Abstract: SIGNIFICANCE Pentosan polysulfate sodium (PPS) maculopathy is a clinical entity characterized by a pigmentary maculopathy in the setting of chronic exposure to PPS. Pentosan polysulfate sodium is indicated for discomfort related to interstitial cystitis/painful bladder… read more here.
Keywords: diagnosed pattern; pattern macular; pentosan polysulfate; case report ... See more keywords
Risk of maculopathy with pentosan polysulfate sodium use
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15303
Abstract: Recent epidemiologic studies have examined the risk of maculopathy with pentosan polysulfate sodium (PPS), a drug indicated for the treatment of interstitial cystitis. However, results have been contradictory. Thus, we quantified the risk of maculopathy… read more here.
Keywords: polysulfate sodium; pentosan polysulfate; maculopathy pentosan; risk maculopathy ... See more keywords